Biolinq has raised $100 million in venture capital financing to help complete the development of its wearable glucose ...

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Connected patches can be used to monitor vital patient parameters in real time, including heart rate, oxygen saturation, ...

The Series C funding supports Biolinq’s transition from development stage to commercial readiness following US pivotal trial ...

Diabetes Care 20, 433–437 (1997). Arnowitz, J. TD glucose patch. (NASA/JDF technology workshop abstracts on non/minimally invasive measurement of physiological analytes, Washington, DC ...

SAN DIEGO – Biolinq, a healthcare technology company of biosensors, has received a $100 million Series C financing led by Alpha Wave Ventures ...

I’ll be out there,” the singer said after his victory. Hines, who suffers from diabetes, wore a glucose monitoring patch. Picture: Seven. While Marshall was a fan favourite, Idol producers ...

A popular trend of wearing continuous glucose monitors for peak performance and health may be rushing ahead of the evidence, ...

Biolinq’s glucose sensor patch placed on the upper forearm features a color-changing indicator light, providing users with real-time feedback to stay informed about glucose excursions.